A Phase IIa Study Investigating the Tolerance, Efficacy and Safety of HSK3486
Clinical trial NCT03698617 · COMPLETED
Trial details
- NCT number
- NCT03698617
- Sponsor
- Sichuan Haisco Pharmaceutical Group Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-06
- Primary completion
- 2018-06-29
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.